LON:CRW - Craneware Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 2,725
  • Forecasted Upside: 48.10 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 1,840
▼ -25 (-1.34%)

This chart shows the closing price for CRW by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Craneware Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRW and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRW

Analyst Price Target is GBX 2,725
▲ +48.10% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Craneware in the last 3 months. The average price target is GBX 2,725, with a high forecast of GBX 0 and a low forecast of GBX 0. The average price target represents a 48.10% upside from the last price of GBX 1,840.

This chart shows the closing price for CRW for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Craneware. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/6/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/3/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/30/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/22/2022Berenberg BankReiterated RatingBuyGBX 2,725
3/14/2022Berenberg BankLower Price TargetBuyGBX 3,100 ➝ GBX 2,725
2/1/2022Berenberg BankReiterated RatingBuyGBX 3,100
12/1/2021Berenberg BankReiterated RatingBuyGBX 3,100
11/4/2021Berenberg BankBoost Price TargetBuyGBX 2,750 ➝ GBX 3,100
6/11/2021Berenberg BankReiterated RatingBuyGBX 2,420
3/1/2021Berenberg BankBoost Price TargetBuyGBX 2,200 ➝ GBX 2,420
7/9/2020Berenberg BankReiterated RatingBuy
7/8/2020Peel HuntReiterated RatingBuy
6/5/2020Berenberg BankReiterated RatingBuyGBX 2,200
4/16/2020Peel HuntReiterated RatingBuy
3/31/2020Berenberg BankLower Price TargetBuyGBX 2,500 ➝ GBX 2,200
3/10/2020Peel HuntReiterated RatingBuy
3/3/2020Peel HuntReiterated RatingBuy
2/24/2020Peel HuntReiterated RatingBuy
1/27/2020Panmure GordonReiterated RatingHold
1/23/2020Peel HuntReiterated RatingBuyGBX 3,000
1/23/2020Berenberg BankReiterated RatingBuyGBX 2,500
1/23/2020Peel HuntReiterated RatingBuyGBX 3,000
12/18/2019Peel HuntReiterated RatingBuy
11/12/2019Peel HuntReiterated RatingBuyGBX 3,000
11/12/2019Peel HuntReiterated RatingBuyGBX 3,000
10/8/2019Peel HuntReiterated RatingBuy
9/9/2019Peel HuntReiterated RatingBuy
9/3/2019Berenberg BankReiterated RatingBuyGBX 2,500
9/2/2019Peel HuntReiterated RatingBuy
8/5/2019Peel HuntReiterated RatingBuy
7/4/2019Peel HuntReiterated RatingBuy
7/2/2019Berenberg BankLower Price TargetBuyGBX 3,600 ➝ GBX 2,500
6/28/2019Peel HuntReiterated RatingBuy
6/25/2019Berenberg BankReiterated RatingBuyGBX 3,600
6/17/2019Peel HuntReiterated RatingBuy
4/9/2019Peel HuntReiterated RatingBuy
3/5/2019Peel HuntBoost Price TargetBuyGBX 2,800 ➝ GBX 3,505
2/4/2019Peel HuntReiterated RatingBuy
1/29/2019Berenberg BankReiterated RatingBuyGBX 3,600
12/21/2018Peel HuntReiterated RatingBuy
11/30/2018Peel HuntReiterated RatingBuy
11/26/2018Berenberg BankReiterated RatingBuyGBX 3,600
11/15/2018Berenberg BankInitiated CoverageBuyGBX 3,600
11/2/2018Peel HuntReiterated RatingBuy
10/1/2018Peel HuntReiterated RatingBuy
8/31/2018Peel HuntReiterated RatingBuyGBX 2,500 ➝ GBX 2,800
7/5/2018Peel HuntReiterated RatingBuyGBX 2,100 ➝ GBX 2,500
6/1/2018Peel HuntReiterated RatingBuy
5/3/2018Peel HuntReiterated RatingBuyGBX 2,100
4/4/2018Peel HuntReiterated RatingBuy
3/26/2018Peel HuntReiterated RatingBuyGBX 2,100
3/1/2018Peel HuntReiterated RatingBuyGBX 2,100
2/13/2018Peel HuntReiterated RatingBuyGBX 2,100
2/1/2018Peel HuntReiterated RatingBuyGBX 1,800
1/3/2018Peel HuntReiterated RatingBuyGBX 1,800
12/4/2017Peel HuntReiterated RatingBuyGBX 1,800
11/8/2017Peel HuntReiterated RatingBuyGBX 1,800
10/31/2017Peel HuntBoost Price TargetBuyGBX 1,495 ➝ GBX 1,800
10/2/2017Peel HuntReiterated RatingBuyGBX 1,495
9/5/2017N+1 SingerReiterated RatingHold
9/4/2017Peel HuntReiterated RatingBuyGBX 1,450
7/11/2017Peel HuntBoost Price TargetBuyGBX 1,450 ➝ GBX 1,495
(Data available from 7/1/2017 forward)

News Sentiment Rating

0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/3/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/2/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/1/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/3/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/2/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/2/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/1/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/1/2022

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Craneware logo
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; trisus pricing transparency; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers customer success management and consulting services; professional services; and sales and marketing, and product and software development services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
Read More

Today's Range

Now: GBX 1,840
Low: 1,755
High: 1,920

50 Day Range

MA: GBX 1,549.41
Low: 1,340
High: 1,875

52 Week Range

Now: GBX 1,840
Low: 1,340
High: 2,700

Volume

12,806 shs

Average Volume

54,093 shs

Market Capitalization

£653.97 million

P/E Ratio

76.99

Dividend Yield

1.50%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Craneware?

The following Wall Street analysts have issued reports on Craneware in the last year: Berenberg Bank.
View the latest analyst ratings for CRW.

What is the current price target for Craneware?

0 Wall Street analysts have set twelve-month price targets for Craneware in the last year. Their average twelve-month price target is GBX 2,725, suggesting a possible upside of 48.1%.
View the latest price targets for CRW.

What is the current consensus analyst rating for Craneware?

Craneware currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CRW will outperform the market and that investors should add to their positions of Craneware.
View the latest ratings for CRW.

How do I contact Craneware's investor relations team?

Craneware's physical mailing address is 1 Tanfield, EDINBURGH, EH3 5DA, United Kingdom. The company's listed phone number is +44-131-5503100. The official website for Craneware is public.craneware.com. Learn More about contacing Craneware investor relations.